GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (XBRU:NYXH) » Definitions » Cash-to-Debt

Nyxoah (XBRU:NYXH) Cash-to-Debt : 3.48 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nyxoah Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Nyxoah's cash to debt ratio for the quarter that ended in Mar. 2024 was 3.48.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Nyxoah could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Nyxoah's Cash-to-Debt or its related term are showing as below:

XBRU:NYXH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.68   Med: 6.69   Max: 11.61
Current: 3.48

During the past 7 years, Nyxoah's highest Cash to Debt Ratio was 11.61. The lowest was 0.68. And the median was 6.69.

XBRU:NYXH's Cash-to-Debt is ranked better than
58.97% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 1.89 vs XBRU:NYXH: 3.48

Nyxoah Cash-to-Debt Historical Data

The historical data trend for Nyxoah's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Nyxoah Cash-to-Debt Chart

Nyxoah Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial 0.68 8.00 11.61 7.98 4.55

Nyxoah Quarterly Data
Dec17 Dec18 Jun19 Dec19 Mar20 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.63 6.64 5.60 4.55 3.48

Competitive Comparison of Nyxoah's Cash-to-Debt

For the Medical Instruments & Supplies subindustry, Nyxoah's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nyxoah's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Nyxoah's Cash-to-Debt falls into.



Nyxoah Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Nyxoah's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Nyxoah's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nyxoah  (XBRU:NYXH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Nyxoah Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Nyxoah's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Nyxoah (XBRU:NYXH) Business Description

Traded in Other Exchanges
Address
Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.